Cargando…
Endothelial fatty liver binding protein 4: a new targetable mediator in hepatocellular carcinoma related to metabolic syndrome
Metabolic syndrome (MS) is becoming the leading risk factor for hepatocellular carcinoma (HCC). HCC development related to MS may occur in advanced or non-advanced liver fibrosis, suggesting specific molecular pathways. Among these pathways, basal inflammatory state and adipokines production are inv...
Autores principales: | Laouirem, Samira, Sannier, Aurélie, Norkowski, Emma, Cauchy, François, Doblas, Sabrina, Rautou, Pierre Emmanuel, Albuquerque, Miguel, Garteiser, Philippe, Sognigbé, Laura, Raffenne, Jerôme, van Beers, Bernard E., Soubrane, Olivier, Bedossa, Pierre, Cros, Jerôme, Paradis, Valérie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484689/ https://www.ncbi.nlm.nih.gov/pubmed/30575815 http://dx.doi.org/10.1038/s41388-018-0597-1 |
Ejemplares similares
-
MALDI Imaging, a Powerful Multiplex Approach to Decipher Intratumoral Heterogeneity: Combined Hepato-Cholangiocarcinomas as Proof of Concept
por: Gigante, Elia, et al.
Publicado: (2023) -
Viscoelastic Parameters for Quantifying Liver Fibrosis: Three-Dimensional Multifrequency MR Elastography Study on Thin Liver Rat Slices
por: Ronot, Maxime, et al.
Publicado: (2014) -
Reply to: “Malignant transformation of hepatocellular adenoma”
por: Chopinet, Sophie, et al.
Publicado: (2022) -
Prognostic Biomarkers in Pancreatic Cancer: Avoiding Errata When Using the TCGA Dataset
por: Nicolle, Remy, et al.
Publicado: (2019) -
A new NRF2 activator for the treatment of human metabolic dysfunction-associated fatty liver disease
por: Hammoutene, Adel, et al.
Publicado: (2023)